BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29743351)

  • 1. Survival of syngeneic and allogeneic iPSC-derived neural precursors after spinal grafting in minipigs.
    Strnadel J; Carromeu C; Bardy C; Navarro M; Platoshyn O; Glud AN; Marsala S; Kafka J; Miyanohara A; Kato T; Tadokoro T; Hefferan MP; Kamizato K; Yoshizumi T; Juhas S; Juhasova J; Ho CS; Kheradmand T; Chen P; Bohaciakova D; Hruska-Plochan M; Todd AJ; Driscoll SP; Glenn TD; Pfaff SL; Klima J; Ciacci J; Curtis E; Gage FH; Bui J; Yamada K; Muotri AR; Marsala M
    Sci Transl Med; 2018 May; 10(440):. PubMed ID: 29743351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival and differentiation of human embryonic stem cell-derived neural precursors grafted spinally in spinal ischemia-injured rats or in naive immunosuppressed minipigs: a qualitative and quantitative study.
    Kakinohana O; Juhasova J; Juhas S; Motlik J; Platoshyn O; Galik J; Hefferan M; Yuan SH; Vidal JG; Carson CT; van Gorp S; Goldberg D; Leerink M; Lazar P; Marsala S; Miyanohara A; Keshavarzi S; Ciacci JD; Marsala M
    Cell Transplant; 2012; 21(12):2603-19. PubMed ID: 22889456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the Post-Spinal Cord Injury Microenvironment on the Differentiation Capacity of Human Neural Stem Cells Derived from Induced Pluripotent Stem Cells.
    López-Serrano C; Torres-Espín A; Hernández J; Alvarez-Palomo AB; Requena J; Gasull X; Edel MJ; Navarro X
    Cell Transplant; 2016 Oct; 25(10):1833-1852. PubMed ID: 27075820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human neural progenitors derived from integration-free iPSCs for SCI therapy.
    Liu Y; Zheng Y; Li S; Xue H; Schmitt K; Hergenroeder GW; Wu J; Zhang Y; Kim DH; Cao Q
    Stem Cell Res; 2017 Mar; 19():55-64. PubMed ID: 28073086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human-induced pluripotent stem cells generated from intervertebral disc cells improve neurologic functions in spinal cord injury.
    Oh J; Lee KI; Kim HT; You Y; Yoon DH; Song KY; Cheong E; Ha Y; Hwang DY
    Stem Cell Res Ther; 2015 Jun; 6(1):125. PubMed ID: 26104416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplanted Human Induced Pluripotent Stem Cell-Derived Neural Progenitor Cells Do Not Promote Functional Recovery of Pharmacologically Immunosuppressed Mice With Contusion Spinal Cord Injury.
    Pomeshchik Y; Puttonen KA; Kidin I; Ruponen M; Lehtonen S; Malm T; Åkesson E; Hovatta O; Koistinaho J
    Cell Transplant; 2015; 24(9):1799-812. PubMed ID: 25203632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell therapy for spinal cord injury by using human iPSC-derived region-specific neural progenitor cells.
    Kajikawa K; Imaizumi K; Shinozaki M; Shibata S; Shindo T; Kitagawa T; Shibata R; Kamata Y; Kojima K; Nagoshi N; Matsumoto M; Nakamura M; Okano H
    Mol Brain; 2020 Sep; 13(1):120. PubMed ID: 32883317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial Effect of Human Induced Pluripotent Stem Cell-Derived Neural Precursors in Spinal Cord Injury Repair.
    Romanyuk N; Amemori T; Turnovcova K; Prochazka P; Onteniente B; Sykova E; Jendelova P
    Cell Transplant; 2015; 24(9):1781-97. PubMed ID: 25259685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of induced pluripotent stem cell technologies in spinal cord injury.
    Nagoshi N; Okano H
    J Neurochem; 2017 Jun; 141(6):848-860. PubMed ID: 28199003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. iPSC-derived neural precursor cells: potential for cell transplantation therapy in spinal cord injury.
    Nagoshi N; Okano H
    Cell Mol Life Sci; 2018 Mar; 75(6):989-1000. PubMed ID: 28993834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expandable Sendai-Virus-Reprogrammed Human iPSC-Neuronal Precursors:
    Kobayashi Y; Shigyo M; Platoshyn O; Marsala S; Kato T; Takamura N; Yoshida K; Kishino A; Bravo-Hernandez M; Juhas S; Juhasova J; Studenovska H; Proks V; Driscoll SP; Glenn TD; Pfaff SL; Ciacci JD; Marsala M
    Cell Transplant; 2023; 32():9636897221107009. PubMed ID: 37088987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective long-term immunosuppression in rats by subcutaneously implanted sustained-release tacrolimus pellet: effect on spinally grafted human neural precursor survival.
    Sevc J; Goldberg D; van Gorp S; Leerink M; Juhas S; Juhasova J; Marsala S; Hruska-Plochan M; Hefferan MP; Motlik J; Rypacek F; Machova L; Kakinohana O; Santucci C; Johe K; Lukacova N; Yamada K; Bui JD; Marsala M
    Exp Neurol; 2013 Oct; 248():85-99. PubMed ID: 23748136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of Neural Stem Cells and Progenitors: Neuronal Production and Grafting Applications.
    Zholudeva LV; Jin Y; Qiang L; Lane MA; Fischer I
    Methods Mol Biol; 2021; 2311():73-108. PubMed ID: 34033079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syngeneic Mesenchymal Stem Cells Reduce Immune Rejection After Induced Pluripotent Stem Cell-Derived Allogeneic Cardiomyocyte Transplantation.
    Yoshida S; Miyagawa S; Toyofuku T; Fukushima S; Kawamura T; Kawamura A; Kashiyama N; Nakamura Y; Toda K; Sawa Y
    Sci Rep; 2020 Mar; 10(1):4593. PubMed ID: 32165680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of dosing regimen and reproducibility of intraspinal grafting of human spinal stem cells in immunosuppressed minipigs.
    Usvald D; Vodicka P; Hlucilova J; Prochazka R; Motlik J; Kuchorova K; Johe K; Marsala S; Scadeng M; Kakinohana O; Navarro R; Santa M; Hefferan MP; Yaksh TL; Marsala M
    Cell Transplant; 2010; 19(9):1103-22. PubMed ID: 20412634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low immunogenicity of mouse induced pluripotent stem cell-derived neural stem/progenitor cells.
    Itakura G; Ozaki M; Nagoshi N; Kawabata S; Nishiyama Y; Sugai K; Iida T; Kashiwagi R; Ookubo T; Yastake K; Matsubayashi K; Kohyama J; Iwanami A; Matsumoto M; Nakamura M; Okano H
    Sci Rep; 2017 Oct; 7(1):12996. PubMed ID: 29021610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. iPSC Transplantation increases regeneration and functional recovery after ischemic stroke in neonatal rats.
    Chau MJ; Deveau TC; Song M; Gu X; Chen D; Wei L
    Stem Cells; 2014 Dec; 32(12):3075-87. PubMed ID: 25132189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembling peptides optimize the post-traumatic milieu and synergistically enhance the effects of neural stem cell therapy after cervical spinal cord injury.
    Zweckberger K; Ahuja CS; Liu Y; Wang J; Fehlings MG
    Acta Biomater; 2016 Sep; 42():77-89. PubMed ID: 27296842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human induced pluripotent stem cells are a novel source of neural progenitor cells (iNPCs) that migrate and integrate in the rodent spinal cord.
    Sareen D; Gowing G; Sahabian A; Staggenborg K; Paradis R; Avalos P; Latter J; Ornelas L; Garcia L; Svendsen CN
    J Comp Neurol; 2014 Aug; 522(12):2707-28. PubMed ID: 24610630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells.
    Guha P; Morgan JW; Mostoslavsky G; Rodrigues NP; Boyd AS
    Cell Stem Cell; 2013 Apr; 12(4):407-12. PubMed ID: 23352605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.